These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32938456)

  • 1. Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.
    Tao Y; Yang R; Shu J; Zheng W; Chen J; Wu Y; He Y
    BMC Vet Res; 2020 Sep; 16(1):342. PubMed ID: 32938456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and
    Tao Y; Li G; Zheng W; Shu J; Chen J; Yang F; Wu Y; He Y
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505747
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C; Jeong J; Choi K; Chae C
    Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
    Yang S; Park SJ; Oh T; Cho H; Chae C
    Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
    Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.
    Roques E; Girard A; Gagnon CA; Archambault D
    Vaccine; 2013 May; 31(24):2698-704. PubMed ID: 23583895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Immunization with Attenuated
    Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
    Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
    Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
    BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoenhancement of Recombinant Neisseria meningitides PorB Protein on Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Genetically Engineered Vaccines.
    Yang R; Tao Y; Li G; Chen J; Shu J; He Y
    Protein Pept Lett; 2019; 26(10):776-784. PubMed ID: 31208304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bivalent vaccines of porcine circovirus type 2 and
    Lim J; Jin M; Yoon I; Yoo HS
    J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
    Lee SI; Jeong CG; Ul Salam Mattoo S; Nazki S; Prasad Aganja R; Kim SC; Khatun A; Oh Y; Noh SH; Lee SM; Kim WI
    Vaccine; 2021 Oct; 39(45):6691-6699. PubMed ID: 34538524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field evaluation of a sing-dose bivalent vaccine of porcine circovirus type 2b and Mycoplasma hyopneumoniae.
    Yang S; Ahn Y; Oh T; Cho H; Park KH; Chae C
    Vet Med Sci; 2021 May; 7(3):755-765. PubMed ID: 33386664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field evaluation of a new porcine circovirus type 2d and Mycoplasma hyopneumoniae bivalent vaccine in herds suffering from subclinical PCV2d infection and enzootic pneumonia.
    Ham S; Suh J; Kim C; Seo BJ; Park GS; Chae C
    Vet Med Sci; 2024 Sep; 10(5):e70001. PubMed ID: 39189840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
    Seo HW; Park SJ; Park C; Chae C
    Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
    de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
    Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.